Clinical Trials Directory

Trials / Completed

CompletedNCT04771585

Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19

Quantification of Exhaled Particles to Identify Airborne Transmission Risks of SARS-Co-V-2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

In this study, the aerosols emitted during various respiratory activities will be quantified in healthy subjects. The differences in aerosol size spectrum and number during tidal breathing, speaking, coughing and singing will be assessed. Subjects with an endogenously high aerosol emission will repeat the respiratory activities wearing face masks with varying particle filter capacity to investigate the aerosol emission reduction.

Conditions

Interventions

TypeNameDescription
OTHERCommunity MaskFabric mask, no medical device
OTHERSurgical MaskMedical face mask (personal protective equipment), CE-certified
OTHERFFP2 respiratorFiltering Face Piece with no less than 94% filtering capacity, CE-certified
OTHERFFP3 respiratorFiltering Face Piece with no less than 99% filtering capacity, CE-certified

Timeline

Start date
2021-03-29
Primary completion
2021-08-20
Completion
2021-08-20
First posted
2021-02-25
Last updated
2021-08-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04771585. Inclusion in this directory is not an endorsement.